Home > Insider Trading > Filing (0001384101-19-000016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1588970	H Bonnie Anderson	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-02-26	20,000	$2.68	96,541	No	4	M	Direct
Common Stock	Disposition	2019-02-26	15,300	$20.74	81,241	No	4	S	Direct
Common Stock	Disposition	2019-02-26	4,700	$21.58	76,541	No	4	S	Direct
Common Stock	Acquisiton	2019-02-28	30,000	$0.00	106,541	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-02-26	20,000	$0.00	20,000	$2.68
Common Stock	Stock Option (right to buy)	Acquisiton	2019-02-28	225,000	$0.00	225,000	$20.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,500		2022-03-09	No	4	M	Direct
225,000		2029-02-27	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	99,085	Indirect	The Bonnie H. Anderson Living Trust

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.
Represents weighted average sales price. Sale prices for the transactions range from $20.48 to $21.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Represents weighted average sales price. Sale prices for the transactions range from $21.54 to $21.63. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Restricted stock units awarded on February 28, 2019 vest 25% on March 2, 2020 and 1/16 per quarter thereafter, based on continuing service on each vesting date.
The option is fully vested.
The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.